A controlled trial of tick-borne encephalitis vaccination in patients with multiple sclerosis

Vaccine

Volumn 21, Issue SUPPL. 1, 2003, Pages S56-S61

  Baumhackl, Ulf ^a   Franta, Claudia ^a   Retzl, Johann ^a   Salomonowitz, Erich ^a   Eder, Gerald ^a  

^a Karl Landsteiner Institute for Implementation of Innovative Techniques in Cardiac Surgery   (Austria)

Author keywords

Magnetic resonance imaging; Multiple sclerosis; TBE vaccination

Indexed keywords

TICK BORNE ENCEPHALITIS VACCINE; VIRUS ANTIBODY; VIRUS VACCINE;

ADULT; ARTICLE; BRAIN INJURY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNIZATION; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAPSE; SERODIAGNOSIS; TICK BORNE ENCEPHALITIS; VACCINATION; BLOOD; BRAIN; IMMUNOLOGY; PATHOLOGY; TICK BORNE ENCEPHALITIS FLAVIVIRUS;

ANTIBODIES, VIRAL; BRAIN; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; VIRAL VACCINES;

EID: 0037375426     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00815-0     Document Type: Article

References (29)

1. Thompson N.P., Montgomery S.M., Pounder R.E., Wakefield A.J. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet. 345:1995;1071-1074.
2. Confavreux C., Suissa S., Saddier P., Bourdes V., Vukusic S. Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. N Engl. J. Med. 344:2001;319-326.
3. Ascherio A., Zhang S.M., Hernan M.A., Olek M.J., Coplan P.M., Brodovicz K.et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl. J. Med. 344:2001;327-332.
4. Milne L.M. Difficulties in assessing the relationship, if any, between mumps vaccination and diabetes mellitus in childhood. Vaccine. 19:2000;1018-1025.
5. Tourbah A., Gout O., Liblau R., Lyon-Caen O., Bougniot C., Iba-Zizen M.T.et al. Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS? Neurology. 53:1999;396-401.
6. Plesner A.M., Arlien-Soborg P., Herning M. Neurological complications to vaccination against Japanese encephalitis. Eur. J. Neurol. 5:1998;479-485.
7. Reik L. Jr. Neurological complications of immunization. Neurol. Infect. Epidemiol. 2:1997;69-98.
8. Sibley W.A., Bamford C.R., Clark K. Clinical viral infections and multiple sclerosis. Lancet. 1:1985;1313-1315.
9. Marrie R.A., Wolfson C., Sturkenboom M.C., Gout O., Heinzlef O., Roullet E.et al. Multiple sclerosis and antecedent infections: a case-control study. Neurology. 54:2000;2307-2310.
10. Miller A.E., Morgante L.A., Buchwald L.Y., Nutile S.M., Coyle P.K., Krupp L.B.et al. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology. 48:1997;312-314.
11. De Keyser J., Zwanikken C., Boon M. Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis. J. Neurol. Sci. 159:1998;51-53.
12. Salvetti M., Pisani A., Bastianello S., Millefiorini E., Buttinelli C., Pozzilli C. Influenza immunization in multiple sclerosis. Neurology. 49:1997;1474-1475.
13. Merelli E., Casoni F. Prognostic factors in multiple sclerosis: role of intercurrent infections and vaccinations against influenza and hepatitis B. Neurol. Sci. 21:2000;S853-S856.
14. Poser C.M. Neurological complications of swine influenza vaccination. Acta Neurol. Scand. 66:1982;413-431.
15. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C.et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
16. Poser C.M. The pathogenesis of multiple sclerosis: a commentary. Clin. Neurol. Neurosurg. 102:2000;191-194.
17. Goodkin D.E., Cookfair D., Wende K., Bourdette D., Pullicino P., Scherokman B.et al. Inter- and intrarater scoring agreement using grades 1.0-3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group. Neurology. 42:1992;859-863.
18. Filippi M. Enhanced magnetic resonance imaging in multiple sclerosis. Mult. Scler. 6:2000;320-326.
19. Fazekas F., Barkhof F., Filippi M., Grossman R.I., Li D.K., McDonald W.I.et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology. 53:1999;448-456.
20. Kappos L., Moeri D., Radue E.W., Schoetzau A., Schweikert K., Barkhof F.et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-Analysis Group. Lancet. 20(353):1999;964-969.
21. Kiessig ST, Abel U, Risse P, Friedrich J, Heinz FX, Kunz CH. Bestimmung von Schwellenwerten (Cut-Off) bei Enzymimmunoassays am Beispiel des FSME - ELISA. Problems of cut-off level determination in enzyme immunoassays: the case of TBE-ELISA. Klin. Lab. 1993;11:877-86.
22. Holzmann H., Kundi M., Stiasny K., Clement J., McKenna P., Kunz C.et al. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. J. Med. Virol. 48:1996;102-107.
23. Collard R.C., Koehler R.P., Mattson D.H. Frequency and significance of antinuclear antibodies in multiple sclerosis. Neurology. 49:1997;857-861.
24. Rieckmann P., Tuscano J.M., Kehrl J.H. Tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in B-lymphocyte function. Methods. 11:1997;128-132.
25. Woessner R., Grauer M.T., Haass A., Gaertner B., Holzer G., Mueller-Reiland D.et al. Effects of multiple sclerosis and other inflammatory CNS disorders on tick-borne encephalitis serology. Acta Virol. 43:1999;331-333.
26. Speciale L., Saresella M., Caputo D., Ruzzante S., Mancuso R., Calvo M.G.et al. Serum auto antibodies presence in multiple sclerosis patients treated with beta-interferon 1a and 1b. J. Neurovirol. 6(Suppl. 2):2000;S57-S61.
27. Thompson A.J., Kermode A.G., MacManus D.G., Kendall B.E., Kingsley D.P., Moseley I.F.et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. BMJ. 300:1990;631-634.
28. Baumhackl, U. Früsommer-meningoenzephalitis. In: Henkes, H, Kölmel, W. (Eds.), Die Entzündlichen Erkrankungen des Zentralnervensystems. Handbuch und Atlas. 7. Erg Lfg. ECOMED, 2000;12:1-28.
29. Atkins G.J., McQuaid S., Morris-Downes M.M., Galbraith S.E., Amor S., Cosby S.L.et al. Transient virus infection and multiple sclerosis. Rev. Med. Virol. 10:2000;291-303.